Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA reschedules meeting on ChemGenex's application for Omapro in CML

March 3, 2010

Synta resumes clinical development of elesclomol

March 3, 2010

Bayer Schering claims new polo-like kinase 1 inhibitors

March 3, 2010

Rigel identifies AXL kinase inhibitors for cancer therapy

March 3, 2010

FDA requests Vion conduct phase II trial of Onrigin in AML prior to phase III study

March 2, 2010

Ariad's AP-24534 receives orphan drug status for CML

March 2, 2010

COMP grants perifosine positive opinion as orphan medicinal product in MM

March 2, 2010

UCB presents novel PI3K inhibitors

March 2, 2010

Genentech identifies novel MEK inhibitors

March 2, 2010

AstraZeneca discloses novel FGFR inhibitors

March 2, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...